Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

452
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
452
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

506
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
506
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

856
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
856
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

788
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
788
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

513
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
513

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice.

Clinical microbiology reviews·2025
Same author

GRADE Guidance: Using Thresholds for Judgments on Health Benefits and Harms in Decision Making (GRADE Guidance 42).

Annals of internal medicine·2025
Same author

The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance.

The Lancet. Infectious diseases·2025
Same author

Target regimen profiles for tuberculosis treatment.

Bulletin of the World Health Organization·2024
Same author

Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis.

The Lancet. Global health·2024
Same author

Multidrug-resistant tuberculosis.

Nature reviews. Disease primers·2024

Related Experiment Video

Updated: Jan 3, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.6K

Tuberculosis Supranational Reference Laboratories: A Global Approach.

Christopher Gilpin1, Fuad Mirzayev1

  • 1Global TB Programme, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland.

Clinics in Chest Medicine
|November 17, 2019
PubMed
Summary
This summary is machine-generated.

The World Health Organization Supranational TB Reference Laboratory Network (SRLN) is crucial for global tuberculosis drug-resistance surveillance and diagnosis. However, securing consistent funding for the SRLN has become increasingly difficult.

Keywords:
Drug susceptibility testingQuality assuranceTuberculosisWHO TB supranational reference laboratory

More Related Videos

Amplicon Sequencing using the Long-Read Sequencing Technologies
08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

419
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.7K

Related Experiment Videos

Last Updated: Jan 3, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.6K
Amplicon Sequencing using the Long-Read Sequencing Technologies
08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

419
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.7K

Area of Science:

  • Microbiology
  • Public Health
  • Infectious Disease Surveillance

Background:

  • The World Health Organization Supranational TB Reference Laboratory Network (SRLN) has been vital for tuberculosis (TB) drug-resistance surveillance and diagnosis since 1994.
  • SRLN is a key global program for antimicrobial resistance (AMR) surveillance.
  • It provides essential technical resources for proficiency testing, ensuring accurate drug-susceptibility testing and supporting capacity development in various countries.

Purpose of the Study:

  • To highlight the critical role of the SRLN in global TB control and AMR surveillance.
  • To underscore the SRLN's contributions to diagnostic accuracy and capacity building.
  • To identify the growing challenges in securing sustainable funding for the SRLN.

Main Methods:

  • Review of SRLN's historical contributions and functions.
  • Analysis of SRLN's role in drug-resistance surveillance and diagnostic accuracy.
  • Assessment of funding mechanisms and challenges faced by the SRLN.

Main Results:

  • The SRLN has been instrumental in TB drug-resistance surveillance and diagnosis for decades.
  • SRLN provides essential technical support, including proficiency testing and capacity development.
  • Despite its importance, the SRLN faces increasing funding challenges.

Conclusions:

  • The SRLN is an indispensable resource for global TB and AMR surveillance.
  • Continued technical assistance and reliable detection of drug resistance depend on the SRLN.
  • Addressing the funding challenges is critical to sustain the SRLN's vital operations.